{"id":310526,"date":"2026-08-02T22:18:10","date_gmt":"2026-08-02T22:18:10","guid":{"rendered":"https:\/\/www.europesays.com\/at\/310526\/"},"modified":"2026-08-02T22:18:10","modified_gmt":"2026-08-02T22:18:10","slug":"astrazeneca-und-bristol-myerssquibb-wollen-mega-fusion","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/at\/310526\/","title":{"rendered":"AstraZeneca und Bristol MyersSquibb wollen Mega-Fusion"},"content":{"rendered":"<p>AstraZeneca kommt aktuell auf einen B\u00f6rsenwert von rund 196 Milliarden Pfund (rund 264 Milliarden Dollar), Bristol Myers Squibb auf rund 133 Milliarden Dollar. AstraZeneca-Chef Pascal Soriot w\u00fcrde demnach mit einer Fusion die Ausrichtung auf den US-Markt weiter vorantreiben. Der Konzern, das nach Marktkapitalisierung zweitwertvollste b\u00f6rsennotierte Unternehmen Gro\u00dfbritanniens, hatte erst im Juni seine Notierung in New York aufgewertet. Dies galt als R\u00fcckschlag f\u00fcr den Finanzplatz London. <\/p>\n","protected":false},"excerpt":{"rendered":"AstraZeneca kommt aktuell auf einen B\u00f6rsenwert von rund 196 Milliarden Pfund (rund 264 Milliarden Dollar), Bristol Myers Squibb&hellip;\n","protected":false},"author":2,"featured_media":310527,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[14],"tags":[81074,46,42,95,90,89,1415,91,94,44,6976,93,92,255,877],"class_list":["post-310526","post","type-post","status-publish","format-standard","has-post-thumbnail","category-unternehmen-maerkte","tag-astrazeneca","tag-at","tag-austria","tag-business","tag-companies","tag-companies-markets","tag-grossbritannien","tag-markets","tag-maerkte","tag-oesterreich","tag-pharma","tag-unternehmen","tag-unternehmen-maerkte","tag-wirtschaft","tag-wirtschaft-und-finanzen"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts\/310526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/comments?post=310526"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts\/310526\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/media\/310527"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/media?parent=310526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/categories?post=310526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/tags?post=310526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}